Another Scandal in Evidence-Based Medicine: Ambulatory BP Monitoring Questioned?

Apparently, the scandal surrounding the EXCEL trial kicked the hornet’s nest as far as evidence-based medicine is concerned. This time, the stars were the actual authors of an article published in the prestigious New England Journal of Medicine (NEJM): the investigators retracted their paper due to issues in data analysis.

Otro “escándalo” en la medicina basada en la evidencia ¿El monitoreo ambulatorio de presión puesto en duda?

The aforementioned work was originally published in 2018 in the most prestigious medical journal worldwide, and it showed that ambulatory blood pressure monitoring readings were strongly associated with mortality. In that sense, the association was stronger than with readings obtained at the doctor’s office.

At the time, the lead author had mentioned that his work was the largest worldwide and provided unequivocal evidence that [ambulatory blood pressure monitoring] is superior to clinic pressure at predicting total and cardiovascular mortality. This week, the authors themselves retracted the article due to problems in statistical analyses.


Read also: Latest Guidelines “Dropped” After Scandal Over EXCEL Results.


Now, an independent statistical team is working with the aim of publishing the results as soon as possible.

The original suspicion was confirmed when researchers attempted to replicate findings in the International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes.


Read also: Treating Both Atrial Valves Improves Survival.


Despite everything, ambulatory blood pressure monitoring is still the most suitable method to diagnose and manage hypertension.

2020-03-09-banegas2018 2020-03-09-nejmc2001445

Original title: Retraction: Relationship between clinic and ambulatory blood-pressure measurements a. nd mortality.

Reference: Banegas JR et al. N Engl J Med. 2020; Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...